CSL Ltd
(SYD: AU:CSL)
-0.07
-0.12%
| Exchange: | SYD |
| Stock: | CSL Limited |
| Industry: | Drugs |
| Employees: | 10,515 |
| CSL Limited is an Australia-based company. The Company is engaged in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. The Company operates in three segments: CSL Behring, Intellectual Property Licensing and Other Human Health. CSL Behring manufactures markets and develops plasma products. Intellectual Property Licensing includes revenue and associated expenses from the licensing of Intellectual Property generated by the Group to unrelated third parties. Other Human Health consists of CSL Bioplasma and CSL Biotherapies. These businesses manufacture and distribute biotherapeutic products. It operates in four geographic areas: Australia, the United States of America, Switzerland, and Germany. Its subsidiaries include CSL Employee Share Trust, CSL Biotherapies Pty Ltd, Cervax Pty Ltd, CSL Biotherapies (NZ) Limited, Iscotec AB, Zenyth Therapeutics Pty Ltd, CSL International Pty Ltd and CSL Finance Pty Ltd. |
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
